A new polyclonal antibody that recognizes a human receptor for hyaluronan mediated motility

Cancer Letters

Volumn 210, Issue 1, 2004, Pages 73-80

  Kuwabara, Hiroko ^a   Yoneda, Masahiko ^b   Nagai, Masami ^c   Hayasaki, Hana ^a   Mori, Hiroshi ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b Aichi Prefectural College of Nursing and Health   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

Author keywords

Hyaluronan; Polyclonal antibody; Receptor for hyaluronan mediated motility

Indexed keywords

HYALURONIC ACID; HYALURONIC ACID BINDING PROTEIN; POLYCLONAL ANTIBODY; RECEPTOR FOR HYALURONAN MEDIATED MOTILITY ANTIBODY; RECEPTOR FOR HYALURONAN MEDIATED MOTILITY PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CARBOXY TERMINAL SEQUENCE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IMMUNOREACTIVITY; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN LOCALIZATION;

ANIMALS; ANTIGENS, CD44; CELL MOVEMENT; CELL NUCLEUS; CYTOPLASM; EXTRACELLULAR MATRIX PROTEINS; HUMANS; HYALURONIC ACID; IMMUNIZATION; IMMUNOGLOBULIN G; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; PEPTIDE FRAGMENTS; RABBITS; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED;

EID: 2542468732     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.01.004     Document Type: Article

References (21)

1. Turley E.A., Moore D., Hayden L.J. Characterization of hyaluronate binding proteins isolated from 3T3 and murine sarcoma virus transformed 3T3 cells. Biochemistry. 26:1987;2997-3005
2. Turley E.A., Belch A.J., Poppema S., Pilarski L.M. Expression and function of a receptor for hyaluronan-mediated motility on normal and malignant B lymphocytes. Blood. 81:1993;446-453
3. Greiner J., Ringhoffer M., Taniguchi M., Schmitt A., Kirchner D., Krahn G., Heilmann V., Gschwend J., Bergmann L., Dohner H., Schmitt M. Receptor for hyaluronic acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia. Exp. Hematol. 30:2002;1029-1035
4. Assmann V., Gillett C.E., Poulsom R., Ryder K., Hart I.R., Hanby A.M. The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells. J. Pathol. 195:2001;191-196
5. Assmann V., Kern H.F., Elsasser H.P. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells. Clin. Cancer Res. 2:1996;1607-1618
6. Teder P., Bergh J., Heldin P. Functional hyaluronan receptors are expressed on a squamous cell lung carcinoma cell line but not on other lung carcinoma cell lines. Cancer Res. 55:1995;3908-3914
7. Turley E.A., Austen L., Vandeligt K., Clary C. Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J. Cell Biol. 112:1991;1041-1047
8. Assmann V., Jenkinson D., Marshall J.F., Hart I.R. The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments. J. Cell Sci. 112:1999;3943-3954
9. Maxwell C.A., Keats J.J., Crainie M., Sun X., Yen T., Shibuya E., Hendzel M., Chan G., Pilarski L.M. RHAMM is a centrosomal protein that interacts with dynein and maintains spindle pole stability. Mol. Biol. Cell. 14:2003;2262-2276
10. Hofmann M., Fieber C., Assmann V., Gottlicher M., Sleeman J., Plug R., Howells N., Stein O., Ponta H., Herrlich P. Identification of IHABP, a 95 kDa intracellular hyaluronic binding protein. J. Cell Sci. 111:1998;1673-1684
11. Wang C., Thor A.D., Moore D.H. II, Zhao Y., Kerschmann R., Stern R., Watson P.H., Turley E.A. The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin. Cancer Res. 4:1998;567-576
12. Kuwabara H., Nagai M., Kawakami K., Ohmori M., Tasaka T., Funamoto Y., Yamaoka G., Nishio H., Suzuki K., Mori H. Establishment and characterization of a Kaposi's sarcoma-associated herpesvirus- and Epstein-Barr virus-negative malignant lymphoma cell line (OHK) with primary effusion lymphoma immunophenotype. Br. J. Haematol. 116:2002;128-134
13. Pilarski L.M., Miszta H., Turley E.A. Regulated expression of a receptor for hyaluronan-mediated motility on human thymocytes and T cells. J. Immunol. 150:1993;4292-4302
14. Yu Q., Toole B.P. Biotinylated hyaluronan as a probe for detection of binding proteins in cells and tissues. Biotechniques. 19:1995;122-129
15. Assmann V., Marshall J.F., Fieber C., Hofmann M., Hart I.R. The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells. J. Cell Sci. 111:1998;1685-1694
16. Toole B.P. Proteoglycans and hyaluronan in morphogenesis and differentiation. Hay E.D. Cell Biology of Extracellular Matrix. 1991:1991;305-342 Plenum Press, New York
17. Kuwabara H., Yoneda M., Nagai M., Nishio H., Tasaka T., Suzuki K., Mori H. High levels of hyaluronan production by a malignant lymphoma cell line with primary effusion lymphoma immunophenotype OHK. Br. J. Haematol. 120:2003;1055-1057
18. Crainie M., Belch A.R., Mant M.J., Pilarski L.M. Overexpression of the receptor for hyaluronan-mediated motility (RHAMM) characterizes the malignant clone in multiple myeloma: identification of three distinct RHAMM variants. Blood. 93:1999;1684-1696
19. Masellis-Smith A., Belch A.R., Mant M.J., Turley E.A., Pilarski L.M. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44. Blood. 87:1996;1891-1899
20. Cheung W.F., Cruz T.F., Turley E.A. Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors. Biochem. Soc. Trans. 27:1999;135-142
21. Saito H., Lai J., Rogers R., Doerschuk C.M. Mechanical properties of rat bone marrow and circulating neutrophils and their responses to inflammatory mediators. Blood. 99:2002;2207-2213